Elandas, Inc., a SaaS-based configurable technology solutions provider, announced it has merged with long-standing partner AccessSync, LLC, a US-based strategic market access execution services provider. Together, Elandas and AccessSync leadership combine decades of experience delivering integrated market access planning and execution to accelerate growth in an increasingly complex biopharma market access environment.
AI and ML News: Why SMBs Shouldn’t Be Afraid of Artificial Intelligence (AI)
“We are extremely excited to welcome the AccessSync team to Elandas.”
“This merger is a major step forward in ensuring our technology allows key information to reach clients, health care professionals, and patients, where it will have maximum impact on access and outcomes,” said Ryan Roberts, CEO. “We are extremely excited to welcome the AccessSync team to Elandas.”
Top Artificial Intelligence Insights: Determining the Potential of Your AI Algorithm Starts with Measurement
The new company’s vision is to ensure that innovative biopharma products reach appropriate patients through seamlessly connecting people, data, and resources.
“The Elandas technology platform introduces unrivaled speed and flexibility into this space, combining workflow and data automation with the ability to tailor each individual user experience to specific market access needs,” said Tate Rarick, Managing Director of AccessSync, Inc. “Coming together represents a milestone in our shared quest to unlock the full potential of our customers’ market access strategies through optimized planning and execution.”
A seamless, integrated approach to market access is becoming increasingly important. Specialty products now lead in new drug approvals and often involve complex coverage, distribution, and administration requirements. All these access elements interact, and in combination can significantly impact competitive positioning, office logistics, and patient affordability. There is an emerging need to demystify the market access execution pathway.
“The most exciting aspect of this merger is the ability to integrate data, creative, and technology to drive informed actions,” said Rarick. “Working with our clients and their partners, we can now fully leverage their organizational assets for maximum effectiveness, enabling customized execution down to local market and health care professional levels.”
Read More About AI News : AI Innovation Supports Rural and Remote Internet Connectivity
[To share your insights with us, please write to admin@websitehost.review]
The post Elandas and AccessSync Merger Delivers Seamless Solutions for Market Access Execution appeared first on WebsiteHost.Review.
TL;DR Transparency Builds Trust: While hyperscale AI data centers often face local pushback over resource…
Direct liquid cooling (DLC) has attracted significant investment over the past two years, driven largely…
This guide is for IT leaders, security teams, and small business decision-makers comparing Microsoft Defender…
TL;DR Shift to Edge Automation: Data centers are moving away from inefficient, manually monitored Security…
In April 2026, the US state of Maine’s governor vetoed a state-level data center moratorium…
TL;DR The True Data Center Bottleneck: While power and space often dominate the conversation, the…